0001437749-23-015170.txt : 20230518
0001437749-23-015170.hdr.sgml : 20230518
20230518185352
ACCESSION NUMBER: 0001437749-23-015170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeMaitre George W
CENTRAL INDEX KEY: 0001365737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 23937508
MAIL ADDRESS:
STREET 1: 342 BUNKER HILL STREET, #2B
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-05-16
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365737
LeMaitre George W
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
1
Chairman and CEO
0
Common Stock
2023-05-16
4
M
0
8610
35.48
A
2357923
D
Common Stock
2023-05-16
4
M
0
7837
37.29
A
2365760
D
Common Stock
2023-05-16
4
M
0
7734
48.60
A
2373494
D
Common Stock
2023-05-17
4
S
0
2143
64.05
D
2371351
D
Common Stock
2023-05-17
4
S
0
33
64.82
D
2371318
D
Common Stock
2023-05-18
4
S
0
17660
63.26
D
2353658
D
Common Stock
2023-05-18
4
S
0
250
64.02
D
2353408
D
Stock Option (Right to Buy)
35.48
2023-05-16
4
M
0
8610
0
D
2019-12-20
2026-12-20
Common Stock
8610
17220
D
Stock Option (Right to Buy)
37.29
2023-05-16
4
M
0
7837
0
D
2020-12-02
2027-12-02
Common Stock
7837
23508
D
Stock Option (Right to Buy)
48.60
2023-05-16
4
M
0
7734
0
D
2021-12-11
2028-12-11
Common Stock
7734
23200
D
Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.77 to $64.47 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $62.94 to $63.92 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.94 to $64.27 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years with the final vesting occurring on the eleventh month after the fourth anniversary.
This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
/s/ Val Gertz
2023-05-18